CYP19A1 and endometriosis: GnRH antagonists, aromatase inhibitors, selective progesterone receptor modulators, anti-tumor necrosis factor-ɑ (TNF-ɑ), and anti-angiogenic factors are new treatments for endometriosis [9, 10].